Difference between revisions of "TG003147"

From GPTWiki
Jump to navigation Jump to search
 
(2 intermediate revisions by the same user not shown)
Line 3: Line 3:
 
|mz1=1273.867
 
|mz1=1273.867
 
|nrt=7.178
 
|nrt=7.178
|ntransition=12
+
|ntransition=14
|pepnrt=use (+2.721)
+
|pepnrt=use (+2.836)
 
|peptide=PE000547
 
|peptide=PE000547
 
|prt=17.450
 
|prt=17.450
Line 10: Line 10:
 
|scans=2780;EThcD;17.344;2770;1274.208;Byonic:q-value=2.16e-06/GPS:MinICScore=10.121,2782;HCD;17.352;2770;1274.208;,2883;EThcD;17.719;2872;1273.872;Byonic:q-value=7.32e-06/GPS:MinICScore=42.199,2885;HCD;17.725;2872;1273.872;,2932;EThcD;17.899;2926;1274.206;Byonic:q-value=0.000685/GPS:MinICScore=62.740,2933;HCD;17.904;2926;1274.206;,2947;EThcD;17.962;2945;1274.539;Byonic:q-value=6.9e-05/GPS:MinICScore=184.210,2949;HCD;17.983;2945;1274.539;
 
|scans=2780;EThcD;17.344;2770;1274.208;Byonic:q-value=2.16e-06/GPS:MinICScore=10.121,2782;HCD;17.352;2770;1274.208;,2883;EThcD;17.719;2872;1273.872;Byonic:q-value=7.32e-06/GPS:MinICScore=42.199,2885;HCD;17.725;2872;1273.872;,2932;EThcD;17.899;2926;1274.206;Byonic:q-value=0.000685/GPS:MinICScore=62.740,2933;HCD;17.904;2926;1274.206;,2947;EThcD;17.962;2945;1274.539;Byonic:q-value=6.9e-05/GPS:MinICScore=184.210,2949;HCD;17.983;2945;1274.539;
 
|spectra=MS_48_UO1_Erlic_E5
 
|spectra=MS_48_UO1_Erlic_E5
|transitions=TR009245;64.8,TR009246;31.5,TR009247;23.6,TR009249;20.3,TR009248;14.9,TR009251;11.8,TR019460;8.1,TR009252;6.3,TR009250;7.1,TR009257;6.8,TR009258;5.5,TR019461;5.0
+
|transitions=TR009245;64.8,TR009246;31.5,TR009247;23.6,TR009249;20.3,TR009248;14.9,TR009251;11.8,TR019460;8.1,TR009254;7.5,TR009252;6.3,TR009250;7.1,TR009255;7.1,TR009257;6.8,TR009258;5.5,TR019461;5.0
 
|z1=3
 
|z1=3
 
}}
 
}}

Latest revision as of 17:04, 23 May 2021

Peptide R.VYKPSAGN[H5N4FS2]NSLYR.D (PE000547)
Sequence VYKPSAGNNSLYR
Glycans(s) H5N4FS2 (N8)
Mod(s)
Molecular Weight 3,836.588
Charge 3+
Protein APOH (P02749)
Spectrum File MS_48_UO1_Erlic_E5
Method Orbitrap Fusion-Lumos, DDA (EThcD pd HCD), nano LC-MS/MS
Analytical Fraction SAX-ERLICH Enrichment
Sample Human Serum

Transitions

Exp. R.T. Peak R.T. Norm. R.T. Prec. m/z Prec. z Prod. m/z Prod. z Label %Int
17.725 17.450 7.178 1,273.867 3+ 1,436.635 2+ Y[pH4N3F] 64.8
17.725 17.450 7.178 1,273.867 3+ 1,355.609 2+ Y[pH3N3F] 31.5
17.725 17.450 7.178 1,273.867 3+ 1,582.183 2+ Y[pH4N3FS] 23.6
17.725 17.450 7.178 1,273.867 3+ 1,363.606 2+ Y[pH4N3] 20.3
17.725 17.450 7.178 1,273.867 3+ 1,619.201 2+ Y[pH5N4F] 14.9
17.725 17.450 7.178 1,273.867 3+ 1,282.580 2+ Y[pH3N3] 11.8
17.725 17.450 7.178 1,273.867 3+ 1,501.156 2+ Y[pH3N3FS] 8.1
17.725 17.450 7.178 1,273.867 3+ 1,254.069 2+ Y[pH3N2F]* 7.5
17.725 17.450 7.178 1,273.867 3+ 1,274.582 2+ Y[pH2N3F] 6.3
17.725 17.450 7.178 1,273.867 3+ 1,176.835 3+ Y[pH5N4FS] 7.1
17.725 17.450 7.178 1,273.867 3+ 1,173.042 2+ Y[pH2N2F]* 7.1
17.725 17.450 7.178 1,273.867 3+ 1,100.014 2+ Y[pH2N2] 6.8
17.725 17.450 7.178 1,273.867 3+ 1,181.040 2+ Y[pH3N2] 5.5
17.725 17.450 7.178 1,273.867 3+ 836.421 2+ Y[pN] 5.0

Spectra

2780;EThcD;17.344;2770;1274.208;Byonic:q-value=2.16e-06/GPS:MinICScore=10.121
2782;HCD;17.352;2770;1274.208;
2883;EThcD;17.719;2872;1273.872;Byonic:q-value=7.32e-06/GPS:MinICScore=42.199
2885;HCD;17.725;2872;1273.872;
2932;EThcD;17.899;2926;1274.206;Byonic:q-value=0.000685/GPS:MinICScore=62.740
2933;HCD;17.904;2926;1274.206;
2947;EThcD;17.962;2945;1274.539;Byonic:q-value=6.9e-05/GPS:MinICScore=184.210
2949;HCD;17.983;2945;1274.539;